NEW YORK, March 24 Reportlinker.com announces that a new market research report is available in its catalogue:
Biotechnology (Pharmaceuticals) Report- January 2010 Edition
The Global Biotechnology Report
Plimsoll Publishing Ltd.
Do you know....
The top 7 best trading partners in the industry?
Which company has the highest sales growth?
Which companies have the highest levels of debt?
This report is an in-depth financial evaluation of the Global Biotechnology Industry. Using the unique Plimsoll method of analysis, each of the top 500 Biotechnology Companies is individually assessed and ranked against each other and compared to industry averages. Using the most up-to-date financial information available, the two-page analysis provides detailed financial analysis for each organisation, including details of;
Results are shown in graphical, numeric and narrative forms, and all individual analysis are measured in both the company's own currency, and USD ($) for ease of use. These individual analyses highlight a company's success just as easily as it can emphasise its vulnerability.
Along with individual company information, this report also contains an assessment of the market, based on the companies analysed. This key information identifies;
Companies can change at an alarming rate in a very short space of time, so it is vital that you keep up-to-date with any changes to your market, and how those changes can affect you. This report can provide you with an in-depth look at your industry, highlight new market opportunities and provide important information to help develop accurate strategic business plans. Whether you wish to benchmark your own company's results, study the industry in more depth or have a vast array of industry intelligence at your disposal, this report is the ideal resource.
This extensive report is broken into two parts:
To order this report:
Biotechnology Industry: Biotechnology (Pharmaceuticals) Report- January 2010 Edition
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
-- Sales growth -- Trading stability -- Profitability -- Employee performance -- Level of debt -- Gearing ratio's -- Creditor Exposure -- Performance ratio's -- Overall financial rating